MINAPHARM Pharmaceuticals (EGX:MIPH)

MINAPHARM Pharmaceuticals Revenue

In the year 2024, MINAPHARM Pharmaceuticals had annual revenue of 5.66B EGP with 45.55% growth. MINAPHARM Pharmaceuticals had revenue of 2.08B in the quarter ending December 31, 2024, with 147.41% growth.

• Revenue: 5.66B
• Revenue Growth: +45.55%
• P/S Ratio: 0.45
• Revenue / Employee: 13.97M
• Employees: 450
• Market Cap: 2.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.66B	1.77B	45.55%
Dec 31, 2023	3.89B	271.51M	7.50%
Dec 31, 2022	3.62B	615.19M	20.47%
Dec 31, 2021	3.01B	644.34M	27.29%
Dec 31, 2020	2.36B	309.95M	15.11%